Literature DB >> 16082509

Sleep disorders in multiple system atrophy.

I Ghorayeb1, B Bioulac, F Tison.   

Abstract

Complaints about sleep disorders and excessive daytime sleepiness are common among patients with multiple system atrophy. The diffuse neurodegenerative process that encompasses the key structures involved in the regulation of the sleep/wake transition and respiratory function may account for these complaints and for the most frequent polysomnographic findings in MSA, i.e., sleep-related breathing disturbances and REM sleep behaviour disorder, which are both treatable conditions. Nocturnal stridor is an inspiratory sound produced by complex vocal cord muscle dysfunction. Often occurring with sleep apnoea, stridor is associated with decreased survival. REM sleep behaviour disorder, a parasomnia characterized by loss of normal skeletal muscle atonia during REM sleep with prominent motor activity, is detected in almost all patients. The pathophysiology of both disorders is partially elucidated but increasing evidence points to the role of basal ganglia dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 16082509     DOI: 10.1007/s00702-005-0348-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  45 in total

1.  Laryngeal dystonia in multiple system atrophy.

Authors:  D M Simpson; H Kaufmann; I Sanders; D E Wolfe
Journal:  Muscle Nerve       Date:  1992-10       Impact factor: 3.217

2.  Laryngeal stridor in multiple system atrophy.

Authors:  Mika Yamaguchi; Kimihito Arai; Masato Asahina; Takamichi Hattori
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

3.  REM sleep behaviour disorder as the presenting symptom of multiple system atrophy.

Authors:  F Tison; G K Wenning; N P Quinn; S J Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

4.  Not paralysis, but dystonia causes stridor in multiple system atrophy.

Authors:  Ilaria Maria Merlo; Antonio Occhini; Claudio Pacchetti; Enrico Alfonsi
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

5.  Symposium: Normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature.

Authors: 
Journal:  J Sleep Res       Date:  1993-12       Impact factor: 3.981

6.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Authors:  B F Boeve; M H Silber; J E Parisi; D W Dickson; T J Ferman; E E Benarroch; A M Schmeichel; G E Smith; R C Petersen; J E Ahlskog; J Y Matsumoto; D S Knopman; C H Schenck; M W Mahowald
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

7.  REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.

Authors:  S Gilman; R A Koeppe; R D Chervin; F B Consens; R Little; H An; L Junck; M Heumann
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

8.  Multiple system atrophy: an update.

Authors:  Gregor K Wenning; Felix Geser; Michaela Stampfer-Kountchev; François Tison
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

9.  Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure.

Authors:  F E Munschauer; L Loh; R Bannister; J Newsom-Davis
Journal:  Neurology       Date:  1990-04       Impact factor: 9.910

10.  Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats.

Authors:  K Takakusaki; K Saitoh; H Harada; T Okumura; T Sakamoto
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  19 in total

1.  New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS).

Authors:  Jorge L Juncos; Joash T Lazarus; Emily Graves-Allen; Lisa Shubeck; Michelle Rusin; Gloria Novak; Deborah Hamilton; Julia Rohr; Stephanie L Sherman
Journal:  Neurogenetics       Date:  2011-01-29       Impact factor: 2.660

2.  The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.

Authors:  David J Lin; Katherine L Hermann; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

Review 3.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

4.  Ventilatory and cardiovascular responses to hypercapnia and hypoxia in multiple-system atrophy.

Authors:  Axel Lipp; James D Schmelzer; Phillip A Low; Bruce D Johnson; Eduardo E Benarroch
Journal:  Arch Neurol       Date:  2010-02

5.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

Review 6.  Sleep Abnormalities in MultipleSystem Atrophy.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

Review 7.  Current Treatment of Multiple System Atrophy.

Authors:  Sylvia Maaß; Johannes Levin; Günter Höglinger
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

Review 8.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

9.  Clinical and polysomnographic features of patients with multiple system atrophy in Southwest China.

Authors:  Xiao Yan Guo; Bei Cao; Fei Lei; Lili Huang; Ke Chen; Wei Song; Bi Zhao; Xiangdong Tang; Huifang Shang
Journal:  Sleep Breath       Date:  2013-04-06       Impact factor: 2.816

Review 10.  Current Concepts in the Treatment of Multiple System Atrophy.

Authors:  Santiago Perez-Lloret; Olivier Flabeau; Pierre-Olivier Fernagut; Anne Pavy-Le Traon; María Verónica Rey; Alexandra Foubert-Samier; Francois Tison; Olivier Rascol; Wassilios G Meissner
Journal:  Mov Disord Clin Pract       Date:  2015-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.